NYSE · SERVICES-MEDICAL LABORATORIES · SMALL CAP
American Shared Hospital Services AMS
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$28.1M
▼ 0.9% vs FY2024
EPS · FY25
$-0.23
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-6.3%
Net margin · FY25
-5.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 28.1M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 6 cents on every revenue dollar this year.
Per share
USD -0.23
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-6.3%
Return on equity, FY2025
ROE
Operating margin-12.8%
Net margin-5.5%
Return on assets-2.7%
Each USD of equity lost 6 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+9.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+12.5%
+9.5%
+5.4%
+3.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years+13.5%
Change, 10 years+22.6%
The share count grew 14% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 55.5M
total assets, end of FY2025
Total assetsUSD 55.5M
EquityUSD 24.0M
CashUSD 3.5M
Gross debtUSD 17.3M
Net debtUSD 13.8M
Current ratio0.76×
Net debt stands at 58% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
·
·
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Income tax $B
−0.0
−0.0
0.0
0.0
0.0
−0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
EPS, diluted $
−0.23
0.33
0.10
0.21
0.03
−1.14
0.11
0.17
0.33
0.17
−0.28
−0.19
−0.07
0.01
0.11
0.01
−0.04
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−6.3
9.1
2.8
6.4
1.0
−31.2
2.6
4.2
8.5
4.5
−7.3
−4.6
−1.6
0.2
2.5
0.3
·
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
63 of 64
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 1 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed